Petros Pharmaceuticals Inc (PTPI)
0.70
+0.08
(+12.02%)
USD |
NASDAQ |
May 21, 10:51
Petros Pharmaceuticals Cash from Operations (Quarterly): -1.135M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.135M |
December 31, 2023 | -2.260M |
September 30, 2023 | -4.046M |
June 30, 2023 | -0.5721M |
March 31, 2023 | -0.7484M |
December 31, 2022 | -1.570M |
September 30, 2022 | -1.752M |
June 30, 2022 | -4.200M |
March 31, 2022 | -5.276M |
Date | Value |
---|---|
December 31, 2021 | -8.304M |
September 30, 2021 | -1.211M |
June 30, 2021 | -1.900M |
March 31, 2021 | -0.4466M |
December 31, 2020 | -4.523M |
September 30, 2020 | -2.667M |
June 30, 2020 | -5.74M |
March 31, 2020 | -2.375M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.304M
Minimum
Dec 2021
-0.4466M
Maximum
Mar 2021
-2.866M
Average
-2.260M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
Avalo Therapeutics Inc | -6.202M |
Imunon Inc | -5.874M |
iBio Inc | -3.654M |
Ocugen Inc | -10.60M |
Gritstone Bio Inc | -33.57M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | -1.121M |
Free Cash Flow | -8.013M |
Free Cash Flow Per Share (Quarterly) | -0.2386 |
Free Cash Flow to Equity (Quarterly) | -1.135M |
Free Cash Flow to Firm (Quarterly) | -1.135M |
Free Cash Flow Yield | -402.6% |